Carlos Portera-Cailliau, M.D., Ph.D. on EPAC2 As Potential Therapeutic Target in Fragile X Syndromehttps://www.contemporarypediatrics.com/view/epac2-identified-as-potential-therapeutic-target-in-fragile-x-syndrome 5Jun Carlos Portera-Cailliau, M.D., Ph.D. Share Post
